SOLACI lamenta el fallecimiento de la Dra. Liliana Grinfeld

La Sociedad Latinoamericana de Cardiología Intervencionista (SOLACI) lamenta comunicar que en el día de la fecha ha fallecido la Dra.  Liliana Grinfeld, reconocida y prestigiosa cardióloga intervencionista de Argentina. 

Oriunda de la Ciudad de La Plata, se formó y trabajó codo a codo junto al Dr. René Favaloro, con quien colaboró en la Cleveland Clinic de los Estados Unidos, y más tarde en la Fundación que lleva su nombre. 

Fue la primera mujer en presidir la Sociedad Argentina de Cardiología (SAC) y la Fundación Cardiológica Argentina (FCA). A mediados de los años 90’s también dirigió el Colegio Argentino de Cardioangiólogos Intervencionistas (CACI).

En 2006 el Ministerio de Salud y Acción Social de Argentina le otorgó el premio Mujeres Destacadas en Salud. En los últimos años integró los servicios de Hemodinamia del Hospital Español de La Plata y de la Clínica San Camilo de Buenos Aires. 

SOLACI lamenta el fallecimiento de esta valiosa colega y envia el pésame a sus familiares

SOLACI

More articles by this author

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...